SU1388792A1 - Method of isoelectric focusing of ampholyte - Google Patents
Method of isoelectric focusing of ampholyte Download PDFInfo
- Publication number
- SU1388792A1 SU1388792A1 SU854004396A SU4004396A SU1388792A1 SU 1388792 A1 SU1388792 A1 SU 1388792A1 SU 854004396 A SU854004396 A SU 854004396A SU 4004396 A SU4004396 A SU 4004396A SU 1388792 A1 SU1388792 A1 SU 1388792A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- exchangers
- lysine
- ampholytes
- glutamic acid
- anion
- Prior art date
Links
- 239000000872 buffer Substances 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title claims abstract description 7
- 238000001155 isoelectric focusing Methods 0.000 title claims abstract description 5
- 238000000926 separation method Methods 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 7
- 150000001450 anions Chemical class 0.000 claims abstract description 5
- 239000002253 acid Substances 0.000 claims abstract description 4
- 150000001768 cations Chemical class 0.000 claims abstract 6
- 238000003795 desorption Methods 0.000 claims abstract 5
- 238000011033 desalting Methods 0.000 claims abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 12
- 239000004472 Lysine Substances 0.000 claims description 12
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 11
- 235000013922 glutamic acid Nutrition 0.000 claims description 11
- 239000004220 glutamic acid Substances 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 9
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 7
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 4
- 230000000052 comparative effect Effects 0.000 claims description 4
- 239000002594 sorbent Substances 0.000 claims description 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 3
- 239000003957 anion exchange resin Substances 0.000 claims description 3
- 238000002474 experimental method Methods 0.000 claims description 3
- 150000002500 ions Chemical class 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 239000003480 eluent Substances 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 2
- 238000001125 extrusion Methods 0.000 claims 1
- 239000003456 ion exchange resin Substances 0.000 claims 1
- 229920003303 ion-exchange polymer Polymers 0.000 claims 1
- 125000001453 quaternary ammonium group Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000001179 sorption measurement Methods 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 abstract description 3
- 108090000623 proteins and genes Proteins 0.000 abstract description 3
- 239000003513 alkali Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000007790 solid phase Substances 0.000 abstract 1
- 229960003646 lysine Drugs 0.000 description 5
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- QIVUCLWGARAQIO-OLIXTKCUSA-N (3s)-n-[(3s,5s,6r)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1h-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide Chemical compound C1([C@H]2[C@H](N(C(=O)[C@@H](NC(=O)C=3C=C4C[C@]5(CC4=NC=3)C3=CC=CN=C3NC5=O)C2)CC(F)(F)F)C)=C(F)C=CC(F)=C1F QIVUCLWGARAQIO-OLIXTKCUSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229960005337 lysine hydrochloride Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- -1 sulfopropyl Chemical group 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Abstract
Изобретение относитс к способу изоэлектрического фокусировани амфолитов и может быть использовано в хрома ографической технике дл разделени белковых смесей. Изобретение позвол ет увеличить раздел ющ по способность с одновременным обессолива- нием (разделение амфолитов на фрак- ции, отличающиес по рН на 1-2). Эффект достигаетс использованием в качестве твердой фазы катионитов в водородной форме и анионитов в гид- роксильной форме и десорбцией амфолитов с катионитов раствором щелочи и с анионитов раствором кислоты. 1 ил.This invention relates to an isoelectric focusing method of ampholytes and can be used in a chromo graphic technique for the separation of protein mixtures. The invention allows to increase the separation capacity with simultaneous desalting (separation of ampholytes into fractions differing in pH by 1-2). The effect is achieved by using as the solid phase cation exchangers in hydrogen form and anion exchangers in hydroxyl form and desorption of ampholytes with cation exchangers with alkali solution and with anion exchangers with acid solution. 1 il.
Description
Изобретение относитс к биохимии, а именно к способам разделени белковых смесей, и может найти применение в производстве узких фракций ам- фолитов носителей, аминокислот и дл разделени петидов и белков по их изоэлектрическим точкам.The invention relates to biochemistry, in particular, to methods for separating protein mixtures, and can be used in the production of narrow fractions of amphipolytes of carriers, amino acids, and for separating petids and proteins according to their isoelectric points.
Целью изобретени вл етс увели The aim of the invention is to increase
79227922
фракци х 4-9 и глутаминова кислота во фракци х 9-13.fractions 4-9 and glutamic acid in fractions 9-13.
Пример4. На колонку, содержащую 9 мл аниоиообменной смолы Сепа- рон HEMAQ,наход щейс в ОН -форме, нанос т 5 мл раствора, содержащего по 0,5 ммоль глутаминовой кислоты, серина и гидрохлорида лизина. ПровоExample4. A 5 ml solution containing 0.5 mmol of glutamic acid, serine, and lysine hydrochloride is applied to a column containing 9 ml of Separon HEMAQ anion exchange resin in OH-form. Provo
чение раздел ющей способности и ynpo-jg втеснение 0,1 М раствором НС1, щение технологии разделени .separation capacity and ynpo-jg injection with 0.1 M HC1 solution, separation technology separation.
На чертеже изображены диаграммы оптического поглощени и рН фракций.The drawing shows optical absorption diagrams and pH fractions.
Пример. В колонку объемом 10 мл с катионообменной смолой Агаро-15 ЗОЙ 4В, содержащей IО мкмоль/мл SOj- групп в протонированной форме, внос т 50 мл раствора, содержащего 0,1% амфолитов-носителей (дл изоэлектри- ческого фокусировани в диапазоне рН 4-7), представл ющих собой смесь полиаминополикарбоновых кислот с изо- электрическими точками, лежащими в диапазоне рН 3,5-10,0, 0,5 мг ично- го белка и затем вытесн ют фракции 6 мМ раствором .Example. A 10 ml column with a cation-exchange resin Agaro-15 ZOY 4B containing IO µmol / ml SOj-groups in protonated form is added with 50 ml of a solution containing 0.1% ampholytes (for isoelectric focusing in the pH 4 range). -7), which are a mixture of poly-aminopolycarboxylic acids with iso-electric points lying in the pH range 3.5–10.0, 0.5 mg of egg protein, and then displace the fractions with a 6 mM solution.
Пример2. В 17-миллиметровую колонку с катионообменной смолой SP- Сефадекс С-25 в протонированной форме , емкость по Na ионам 2,5 ммоль/г сухой смолы (полисахарид с сульфопро- пильными фрагментами), внос т 5 мл раствора, содержащего 5% амфолитов- носителей диапазона рН 4-9 и 1% NaCl. Вытесн ют 10 мМ раствором КОН ив диапазоне рН 4-9 собирают 10 фракций по 7 мл кажда . Фракции свободны отExample2. A 17-mm column with a cation-exchange resin SP-Sephadex C-25 in the protonated form, capacity for Na ions 2.5 mmol / g of dry resin (a polysaccharide with sulfopropyl fragments) is added with 5 ml of a solution containing 5% ampholytes. carriers in the range of pH 4-9 and 1% NaCl. Squeezed out with a 10 mM KOH solution. In the pH range 4-9, 10 fractions of 7 ml each are collected. Fractions free from
2020
2525
30thirty
3535
при этом лизин находитс в эффлюент с 6,0 до 12,7 мл, серии с 10,6 до 24,8 мл, глутаминова кислота с 24 до 29,8 мл.while lysine is in effluent from 6.0 to 12.7 ml, series from 10.6 to 24.8 ml, glutamic acid from 24 to 29.8 ml.
Пример 5 (сравнительный). Опыт осуществл ют аналогично описан ному в примере 4, но нанесенную про бу далее элюируют раствором глутами новой кислоты и лизина (по 0,75 мМ каждый). Лизин находитс с 5 по 60 м эффлюента, серин с 15 по 28 мл и гл таминова кислота с 26 по 60 мл.Example 5 (comparative). The experiment was carried out similarly to that described in Example 4, but the applied probe was further eluted with a solution of glutamic acid and lysine (0.75 mM each). Lysine is from 5 to 60 m of effluent, serine from 15 to 28 ml and glutamic acid from 26 to 60 ml.
Из результатов видно, что по известному способу лишь перва часть лизина может быть получена в чистом виде, все остальные компоненты посто нно присутствуют в смеси.From the results it can be seen that, by a known method, only the first part of lysine can be obtained in pure form, all other components are permanently present in the mixture.
П р и м е р 6 (сравнительный). Опыт осуществл ют аналогично описан ному в примере 4, но в качестве сор бента используют анионит в CHjCOO - форме. Эффлюент содержит кроме смес амфолитов (лизина, глутаминовой кис лоты и серина) и ионы элюента.PRI me R 6 (comparative). The experiment was carried out similarly to that described in Example 4, but anion exchanger in the CHjCOO - form was used as the sorbent. The effluent contains, in addition to a mixture of ampholytes (lysine, glutamic acid and serine), and eluent ions.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU854004396A SU1388792A1 (en) | 1985-11-19 | 1985-11-19 | Method of isoelectric focusing of ampholyte |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU854004396A SU1388792A1 (en) | 1985-11-19 | 1985-11-19 | Method of isoelectric focusing of ampholyte |
Publications (1)
Publication Number | Publication Date |
---|---|
SU1388792A1 true SU1388792A1 (en) | 1988-04-15 |
Family
ID=21215187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU854004396A SU1388792A1 (en) | 1985-11-19 | 1985-11-19 | Method of isoelectric focusing of ampholyte |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU1388792A1 (en) |
-
1985
- 1985-11-19 SU SU854004396A patent/SU1388792A1/en active
Non-Patent Citations (1)
Title |
---|
Рили В., Уомт Г. Ионообменна хроматографи в аналитической химии. М.: Мир, 1973, с. 220-223. L.A.E.Sluterman, O.Elgersma, Chro- matofocusing: isoelectrie focusing on ionexchaugl columns. I. Chroma- togr. 1978, V. 150, p. 17-30. . * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Haff et al. | Use of electrophoretic titration curves for predicting optimal chromatographic conditions for fast ion exchange chromatography of proteins | |
JP2020501879A (en) | Amphoteric dissociation type ion exchange medium, method of use and method of calibrating separation capacity | |
Rider et al. | An agarose‐based gel‐concentration system for microsequence and mass spectrometric characterization of proteins previously purified in polyacrylamide gels starting at low picomole levels | |
Spitnik-Elson | Fractionation of the ribosomal protein of escherichia coli by ion-exchange chromatography on carboxymethyl cellulose | |
Endo et al. | Separation of biogenic amines in rat brain on a phosphorylated-cellulose column | |
SU1388792A1 (en) | Method of isoelectric focusing of ampholyte | |
Tiselius | Adsorption analysis of amino acid mixtures | |
KR870003056A (en) | Basic amino acid separation method | |
Robinson et al. | Phenyl-Sepharose-mediated detergent-exchange chromatography: its application to exchange of detergents bound to membrane proteins | |
RU2124496C1 (en) | Method of preparing alkali metal citrate | |
Barker et al. | Separations of carbohydrates based on ion exclusion and gel permeation | |
Heald | Studies on the phosphoproteins of brain. 3. Phosphorylserine sequences in brain phosphoprotein | |
Kihara et al. | Elution behaviour of aliphatic carboxylic acids on a strong cation-exchange resin column | |
Felgner et al. | Purification of nonbindable and membrane-bindable mitochondrial hexokinase from rat brain | |
US3770603A (en) | Ampholytes for focusing electrophoresis | |
JP2004537033A (en) | Method for isolating charged compounds | |
Ross | Identification of histidine phosphorylations in proteins using mass spectrometry and affinity‐based techniques | |
Chang et al. | Characterization of methylated neutral amino acids from Escherichia coli ribosomes | |
US3847889A (en) | Protein separation by insoluble,amphoteric ion exchangers | |
Fägerstam et al. | Basic Principles used in the Selection of Monobeads™ ion Exchangers for the Separation of Biopolymers | |
JPS63222200A (en) | Production of avidin | |
JPS60169427A (en) | Method of separation of protein | |
Linhardt et al. | Separation and purification of carbohydrates | |
Hjertén | Fractionation of proteins by hydrophobic interaction chromatography, with reference to serum proteins | |
US4308204A (en) | Process for preparing the third component of the complement from human blood plasma |